Third Phase III trial of oral MS drug Laquinimod initiated

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Third Phase III trial of oral MS drug Laquinimod initiated

Postby MSUK » Thu Aug 09, 2012 12:15 am


Teva Pharmaceutical Industries Ltd. and Active Biotech have provided an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS). The companies are to initiate a third Phase III study of laquinimod, following the written agreement reached with the U.S. Food and Drug Administration (FDA) on the Special Protocol Assessment (SPA).

The third Phase III laquinimod trial CONCERTO will evaluate two doses of the investigational product (0.6mg and 1.2mg) in approximately 1,800 patients for up to 24 months. The primary outcome measure will be confirmed disability progression as measured by the Expanded Disability Status Scale (EDSS).

"The results achieved in the previous Phase III trials of laquinimod support the clinical utility of this compound as a unique treatment option for multiple sclerosis," said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer, Teva Pharmaceutical Industries Ltd. "We are encouraged by the FDA's agreement on the trial design and planned analysis, and look forward to further developing laquinimod as a potential treatment option for RRMS patients."... Read More - ... ageid/1735
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Re: Third Phase III trial of oral MS drug Laquinimod initiat

Postby Luongo » Mon Aug 13, 2012 4:12 pm

Didn't this thing bomb the last trial?
User avatar
Family Member
Posts: 60
Joined: Fri Jan 14, 2011 4:00 pm

Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service